DLAT and squamous cell lung carcinoma: Besides, we demonstrated that DLAT was differently expressed in 15 cancer types for immune subtypes, including ACC, BRCA, CESC, COAD, KIRC, KIRP, LUAD, lung squamous cell carcinoma (LUSC), OV, cervical squamous cell carcinoma and endocervical adenocarcinoma (PCPG), PRAD, READ, SKCM, STAD, and UCEC (Fig. 5A), and was differently expressed in 9 cancer types for molecular subtypes, including ACC, BRCA, ESCA, LGG, OV, PCPG, PRAD, STAD, and UCEC (Fig. 5B).